Clinical Trials Browser

Withdrawn × Irinotecan × Thoracic × Clear all

NCT04543916 2021-03-03

Venetoclax and Irinotecan in Relapsed/Refractory SCLC

Phase 1/2 Withdrawn

Small Cell Lung Carcinoma

NCT01654081 2014-05-30

A Protocol of Irinotecan for Carcinoma of the Lung

Phase 2 Withdrawn

Lung Neoplasms